Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients MEDICAL NEWS Last updated Nov 4, 2024 Share FacebookTwitterGoogle+ReddItWhatsAppPinterestEmail Source link : News-Medica COVIDCOVID19findshighrisklongnirmatrelvirritonavirpatientsreduces Share FacebookTwitterGoogle+ReddItWhatsAppPinterestEmail